Sinopep-allsino Bio Pharmaceutical Co., Ltd. Class ASSE: 688076

"Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd."Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report and Q1 2026 Report

· Issued by Sinopep-allsino Bio Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Reply to Letter of Supervision and Inquiry on Information Disclosure of 2025 Annual Report and Q1 2026 Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Sinopep-allsino Bio Pharmaceutical Co., Ltd. Class A

All Sinopep-allsino Bio Pharmaceutical Co., Ltd. Class A news releases